Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Biochemistry (Mosc) ; 80(1): 74-86, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25754042

RESUMEN

Using the GUSAR program, structure-activity relationships on inhibition of cyclooxygenase-2 (COX-2) catalytic activity were quantitatively analyzed for twenty-six derivatives of 4,5,6,7-tetrahydro-2H-isoindole, 2,3-dihydro-1H-pyrrolyzine, and benzothiophene in the concentration range of 0.6-700 nmol/liter IC50 values. Six statistically significant consensus QSAR models for prediction of IC50 values were designed based on MNA- and QNA-descriptors and their combinations. These models demonstrated high accuracy in the prediction of IC50 values for structures of both training and test sets. Structural fragments of the COX-2 inhibitors capable of strengthening or weakening the desired property were determined using the same program. This information can be taken into consideration on molecular design of new COX-2 inhibitors. It was shown that in most cases, the influence of structural fragments on the inhibitory activity of the studied compounds revealed with the GUSAR program coincided with the results of expert evaluation of their effects based on known experimental data, and this can be used for optimization of structures to change the value of their biological activity.


Asunto(s)
Inhibidores de la Ciclooxigenasa 2/química , Isoindoles/química , Inhibidores de la Ciclooxigenasa 2/farmacología , Isoindoles/farmacología , Modelos Moleculares , Relación Estructura-Actividad Cuantitativa , Tiofenos/química , Tiofenos/farmacología
2.
Biochemistry (Mosc) ; 79(4): 376-84, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24910210

RESUMEN

New potential inhibitors of 5-lipoxygenase (5-LOX) based on the structure of 2-(3-benzoylphenyl)propanoic acid (an active component of the nonsteroidal antiinflammatory drug Ketoprofen) were designed using the SARD-21 program. The docking of these compounds in the active site of 5-LOX suggested that seven compounds can interact with this enzyme. Two of them can also be dual inhibitors of 5-LOX and two isoforms of cyclooxygenase.


Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Inhibidores de la Lipooxigenasa/farmacología , Morfolinas/química , Morfolinas/farmacología , Propionatos/farmacología , Biocatálisis/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Humanos , Inhibidores de la Lipooxigenasa/química , Modelos Moleculares , Estructura Molecular , Propionatos/química , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...